Results 271 to 280 of about 166,355 (310)
Some of the next articles are maybe not open access.

Mechanisms of resistance to cisplatin

1991
A number of changes have been detected in cisplatin-resistant cells, some of which are likely to be directly involved in the mechanism of resistance. The four most cited mechanisms are reduced accumulation, increased glutathione, increased metallothionein, and enhanced DNA repair.
openaire   +2 more sources

Metallothioneins and Cisplatin Resistance

1991
Intrinsic and acquired resistance to antineoplastic agents has severely limited our ability to cure solid tumors. Cis-diamminedichloroplatinum (cisplatin) represents one of the most efficacious agents for the treatment of solid tumors especially testicular, ovarian, bladder, and head and neck carcinomas.
openaire   +1 more source

Overcoming cisplatin resistance in chemotherapy by biomineralization

Chemical Communications, 2013
Nano-solidified intermedias (NSI) of cisplatin were prepared via biomineralization and applied to reverse the drug resistance of cancers in vitro and in vivo by an alternative internalization pathway.
Wei, Chen   +6 more
openaire   +2 more sources

Mechanisms of acquired resistance to cisplatin

1994
Since the discovery of the antitumor activity in rodents of cisplatin (cis-diamminedichloroplatinum(II)) in 1968 [1], the use of this drug in treating human disease has grown to the point where it is now one of the most widely used antineoplastics. Cisplatin has an established role in the treatment of testicular, ovarian, bladder, germ cell, and head ...
openaire   +2 more sources

Cisplatin resistance

Lung Cancer, 1998
S Akiyama   +4 more
openaire   +1 more source

Cisplatin resistance reversal with treatment of Citric acid in cisplatin-resistant cell lines

ABSTRACTGastric cancer (GC) is a prevalent and aggressive malignancy with significant morbidity and mortality rates, posing a major threat to human health globally. While surgery remains the preferred clinical treatment, chemotherapy continues to be the cornerstone for perioperative care, adjuvant therapy, and palliative treatment for patients with ...
Siddhant Chaturvedi, Krishna Venka
openaire   +1 more source

Cellular and molecular determinants of cisplatin resistance

European Journal of Cancer, 1998
Cisplatin and carboplatin are among the most active and widely used cytotoxic anticancer drugs. However, the acquisition or presence of resistance significantly undermines the curative potential of these drugs against many malignancies. Multiple potential mechanisms of resistance have been identified at the cellular and molecular levels. Alterations in
openaire   +2 more sources

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila K Nanayakkara, Kevin Outterson
exaly  

Cisplatin resistance and DNA repair

Cancer Treatment Reviews, 1997
Crul, M.   +3 more
openaire   +3 more sources

Epigenetics of cisplatin resistance

2023
Anne-Marie Baird, Steven G. Gray
openaire   +1 more source

Home - About - Disclaimer - Privacy